| RS1563268652 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS1563268785 |
STAR
|
Health Risk |
Pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS1563275256 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1563275284 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1563275562 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563279045 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS1563288201 |
KMT2C
|
Health Risk |
Pathogenic |
Neoplasm, Neoplasm |
| RS1563290033 |
FDFT1
|
Health Risk |
Likely pathogenic |
Squalene synthase deficiency, Squalene synthase deficiency |
| RS1563292586 |
RHOBTB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 64 |
| RS1563293555 |
HOOK3
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1563301305 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563301527 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1563301954 |
KRIT1
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563302930 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 1, Cerebral cavernous malformation |
| RS1563302941 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563302951 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563303222 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1563305064 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563305269 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563305588 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS1563305648 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563305909 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563306485 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1563307239 |
KRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563307254 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1563309967 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1563312884 |
DDHD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1563313372 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1563319114 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1563321624 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS1563322318 |
ERI1
|
Health Risk |
Likely pathogenic |
Abnormal finger morphology, Coarse facial features |
| RS1563326405 |
PLPBP
|
Health Risk |
Likely pathogenic |
Epilepsy, early-onset |
| RS1563329555 |
WRN
|
Health Risk |
Likely pathogenic |
— |
| RS1563329888 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 1, Retinal dystrophy |
| RS1563330296 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1563330595 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa 1 |
| RS1563331288 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563331663 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1563331742 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1563333233 |
RP1
|
Health Risk |
Pathogenic |
— |
| RS1563338837 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1563338855 |
WRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563339055 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1563339062 |
WRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563339323 |
FDFT1
|
Health Risk |
Likely pathogenic |
Squalene synthase deficiency, Squalene synthase deficiency |
| RS1563340753 |
IKBKB
|
Health Risk |
Pathogenic |
Immunodeficiency 15a, Severe combined immunodeficiency due to IKK2 deficiency |
| RS1563341296 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563351045 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563352011 |
TTI2
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome, Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome |
| RS1563357741 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1563357810 |
MOS
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 20, Oocyte/zygote/embryo maturation arrest 20 |
| RS1563361838 |
IKBKB
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS1563363293 |
TTPA
|
Health Risk |
Likely pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS1563366896 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1563367625 |
CYP7B1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1563376347 |
WRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563376526 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1563376595 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1563376793 |
WRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563382597 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1563385391 |
WRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1563390893 |
CA8
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1563391747 |
SYNE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1563398977 |
CUX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS1563406024 |
FZD3
|
Health Risk |
Likely pathogenic |
Corpus callosum, agenesis of |
| RS1563422304 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Branchiootorenal syndrome 1 |
| RS1563422500 |
EYA1
|
Health Risk |
Likely pathogenic |
— |
| RS1563423589 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, EYA1-related disorder |
| RS1563431044 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563433095 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS1563433902 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with anosmia, Hartsfield-Bixler-Demyer syndrome |
| RS1563435458 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS1563435595 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS1563436030 |
POR
|
Health Risk |
Likely pathogenic |
— |
| RS1563436097 |
POR
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS1563436265 |
FGFR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hartsfield-Bixler-Demyer syndrome, Cerebellar vermis hypoplasia |
| RS1563446668 |
CUX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS1563452322 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563452873 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563452941 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563453866 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563458773 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1563460197 |
CSPP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1563468940 |
ESCO2
|
Health Risk |
Pathogenic |
— |
| RS1563470335 |
CUX1
|
Health Risk |
Likely pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS1563474005 |
TMEM67
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1563477144 |
CFAP418
|
Health Risk |
Pathogenic |
Bardet-biedl syndrome 21, Retinitis pigmentosa |
| RS1563477343 |
CFAP418
|
Health Risk |
Pathogenic |
— |
| RS1563488907 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563490467 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563497529 |
NBN
|
Health Risk |
Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1563497714 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563497719 |
SLC20A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563497733 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563497844 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563497932 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS1563498184 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS1563499381 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563502820 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS1563509743 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |